Narayan Variankaval is a notable inventor based in Plainsboro, NJ (US), recognized for his contributions to pharmaceutical formulations. With a total of three patents to his name, he has made significant strides in the field of drug development.

Latest Patents

Among his latest patents is a solid dosage formulation of an orexin receptor antagonist. This invention is directed to a pharmaceutical composition comprising the compound suvorexant, or a pharmaceutically acceptable salt thereof, along with a concentration-enhancing polymer and, optionally, a pharmaceutically acceptable surfactant. This innovative approach aims to improve the efficacy and delivery of the medication.

Career Highlights

Narayan Variankaval is currently associated with Merck Sharp & Dohme Corporation, where he continues to advance his research and development efforts in the pharmaceutical industry. His work focuses on creating effective drug formulations that can enhance patient outcomes.

Collaborations

He has collaborated with esteemed colleagues such as Paul A Harmon and Michael Lowinger, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Narayan Variankaval's work in pharmaceutical formulations exemplifies the impact of innovative thinking in medicine. His patents reflect a commitment to improving drug delivery systems, ultimately benefiting patients and the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.